CLOSED - Clinical Trial on Secondary Progressive Multiple Sclerosis Varies

Description

A local research facility is seeking participants for a clinical research study on Secondary Progressive Multiple Sclerosis. This is a clinical research study to test the safety and effectiveness of an investigational medication that may help delay disability worsening in patients with non-relapsing Secondary Progressive Multiple Sclerosis (nr-SPMS).

Total study duration, including screening, is approximately 4.5 years with up to 27 doctor’s visits. Visit frequency will be every month for the first 6 months and then every 3 months.

Trial-related procedures and study medication will be provided at no cost.

Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.